Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB23FZL11
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price delivery order is for the supply of XTANDI 80 mg tablets, a specialty oncology medication.
The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. DMS Pharmaceutical Group also holds separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.
The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct federal contract awards. This delivery order is one of many issued to the company by the DLA to fulfill the diverse medical requirements of military personnel and their dependents across DoD healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB23FZL11?
SPE2DB23FZL11 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 29, 2023.
How much is contract SPE2DB23FZL11 worth?
The government has obligated $8,339 on SPE2DB23FZL11.
Is contract SPE2DB23FZL11 an order under another contract?
Yes. SPE2DB23FZL11 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB23FZL11 competed?
The extent of competition for SPE2DB23FZL11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award